Skip to content

New hepatitis C drugs pose many questions

We’re getting there: towards a comprehensive hepatitis C cure

High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men

Telaprevir works well for people with HIV/HCV co-infection

Mark Sulkowski of Johns Hopkins University. Photo by Liz Highleyman / aidsmap.com

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

European recommendations issued on acute hepatitis C infection in patients with HIV

Hepatitis C still increasing in German gay men with HIV, reinfection common

New tool developed to predict success of hepatitis C therapy in HIV/HCV-co-infected patients

High hepatitis C mortality and low clearance rates in HIV/HCV-co-infected patients in France